Advertisement

U.S. markets open in 5 hours 55 minutes

S&P Futures
4,569.50
+11.50(+0.25%)
Dow Futures
35,671.00
+51.00(+0.14%)
Nasdaq Futures
15,574.50
+78.75(+0.51%)
Russell 2000 Futures
2,314.40
+4.10(+0.18%)
Crude Oil
83.63
-0.13(-0.16%)
Gold
1,803.50
-3.30(-0.18%)

Advertisement

Pfizer Inc. (PFE)

NYSE - NYSE Delayed Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

43.15-0.01 (-0.02%)

At close: 4:03PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Engulfing Line (Bullish)

View all chart patterns

Performance Outlook

Previous Close	43.16
Open	43.20
Bid	0.00 x 2200
Ask	0.00 x 1100
Day's Range	42.57 - 43.24
52 Week Range	32.83 - 51.86
Volume	22,838,421
Avg. Volume	32,254,103

Market Cap	241.929B
Beta (5Y Monthly)	0.69
PE Ratio (TTM)	18.42
EPS (TTM)	2.34
Earnings Date	Nov 02, 2021
Forward Dividend & Yield	1.56 (3.61%)
Ex-Dividend Date	Nov 04, 2021
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

-12% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for PFE

Learn more

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Pfizer, Inc.
Analyst Report: Pfizer Inc.Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.
Rating
Fair Value
Economic Moat
15 days agoMorningstar